ContributorsPublishersAdvertisers

Why Dynavax Stock Is Tumbling Today

The Motley Fool
The Motley Fool
 2021-12-03

What happened

Shares of Dynavax Technologies (NASDAQ: DVAX) were tumbling 7.9% lower at 11:04 a.m. ET on Friday. The only news from the company was an announcement after market close on Thursday that it had granted stock options to five new employees that allow them to purchase a total of 58,500 shares.

Were these options enough to cause the biotech stock to fall? No. Companies routinely give stock options to attract and retain employees. The number of shares that can be purchased with these options represents only a tiny sliver of Dynavax's outstanding shares.

The primary reason behind Dynavax's decline today is more likely that its shares are being pulled down with a broader market sell-off. Investors reacted negatively to a disappointing U.S. jobs report.

https://img.particlenews.com/image.php?url=3gQsgy_0dDK51lx00

Image source: Getty Images.

So what

Most stocks fall during an overall stock market pullback. That doesn't necessarily mean that there's any reason for concern.

In Dynavax's case, the company's outlook appears to remain positive. Dynavax's hepatitis B vaccine Heplisav-B continues to enjoy strong momentum. Its Cpg 1018 adjuvant should also be a significant growth driver for the company, as several vaccine makers are using it with their COVID-19 vaccines.

Now what

The most important things for investors to watch with Dynavax over the near term are regulatory filings from the company's Cpg 1018 collaboration partners. Several COVID-19 vaccine makers that use Dynavax's adjuvant expect to submit for Emergency or Conditional Use Authorizations of their vaccines by year end.

10 stocks we like better than Dynavax Technologies
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has tripled the market.*

They just revealed what they believe are the ten best stocks for investors to buy right now... and Dynavax Technologies wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of November 10, 2021

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy .

Comments / 0

Comments / 0